nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP3A4—bone cancer	0.628	1	CbGaD
Methyltestosterone—SLCO1A2—Methotrexate—bone cancer	0.0783	0.256	CbGbCtD
Methyltestosterone—SLC22A8—Methotrexate—bone cancer	0.0682	0.223	CbGbCtD
Methyltestosterone—CYP2B6—Cisplatin—bone cancer	0.0636	0.208	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—bone cancer	0.0426	0.139	CbGbCtD
Methyltestosterone—ALB—Methotrexate—bone cancer	0.0404	0.132	CbGbCtD
Methyltestosterone—CYP3A4—Doxorubicin—bone cancer	0.0131	0.0427	CbGbCtD
Methyltestosterone—Azoospermia—Cisplatin—bone cancer	0.00453	0.111	CcSEcCtD
Methyltestosterone—Oligospermia—Methotrexate—bone cancer	0.00319	0.0783	CcSEcCtD
Methyltestosterone—Oligospermia—Epirubicin—bone cancer	0.00299	0.0733	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—bone cancer	0.00277	0.0678	CcSEcCtD
Methyltestosterone—Azoospermia—Methotrexate—bone cancer	0.00249	0.0609	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—bone cancer	0.00233	0.057	CcSEcCtD
Methyltestosterone—Azoospermia—Doxorubicin—bone cancer	0.00215	0.0528	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Epirubicin—bone cancer	0.00213	0.0523	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Doxorubicin—bone cancer	0.00197	0.0484	CcSEcCtD
Methyltestosterone—Ethinyl Estradiol—NR1I2—bone cancer	0.00155	0.209	CrCbGaD
Methyltestosterone—Embolism venous—Epirubicin—bone cancer	0.00124	0.0304	CcSEcCtD
Methyltestosterone—Embolism venous—Doxorubicin—bone cancer	0.00115	0.0282	CcSEcCtD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0011	0.0642	CbGpPWpGaD
Methyltestosterone—Anaphylactoid reaction—Cisplatin—bone cancer	0.000915	0.0224	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—T—bone cancer	0.000877	0.0511	CbGpPWpGaD
Methyltestosterone—Amenorrhoea—Epirubicin—bone cancer	0.000713	0.0175	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Epirubicin—bone cancer	0.000713	0.0175	CcSEcCtD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000708	0.0412	CbGpPWpGaD
Methyltestosterone—Amenorrhoea—Doxorubicin—bone cancer	0.00066	0.0162	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—bone cancer	0.00066	0.0162	CcSEcCtD
Methyltestosterone—Allylestrenol—CYP3A4—bone cancer	0.000659	0.0891	CrCbGaD
Methyltestosterone—AR—Nuclear Receptors—NR1I2—bone cancer	0.000633	0.0369	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—FEV—bone cancer	0.000604	0.0352	CbGpPWpGaD
Methyltestosterone—Gynaecomastia—Methotrexate—bone cancer	0.000599	0.0147	CcSEcCtD
Methyltestosterone—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.000595	0.0346	CbGpPWpGaD
Methyltestosterone—Alopecia—Cisplatin—bone cancer	0.000541	0.0133	CcSEcCtD
Methyltestosterone—Hydrocortamate—CYP3A4—bone cancer	0.000537	0.0727	CrCbGaD
Methyltestosterone—Cortisone acetate—CYP3A4—bone cancer	0.000529	0.0715	CrCbGaD
Methyltestosterone—Etonogestrel—CYP3A4—bone cancer	0.000514	0.0694	CrCbGaD
Methyltestosterone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000502	0.0123	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0005	0.0291	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—FOLR1—bone cancer	0.000476	0.0277	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP4V2—bone cancer	0.000474	0.0276	CbGpPWpGaD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—bone cancer	0.00047	0.0115	CcSEcCtD
Methyltestosterone—Eplerenone—CYP3A4—bone cancer	0.000464	0.0628	CrCbGaD
Methyltestosterone—Anxiety—Cisplatin—bone cancer	0.000452	0.0111	CcSEcCtD
Methyltestosterone—Drospirenone—PTGS2—bone cancer	0.000436	0.0589	CrCbGaD
Methyltestosterone—Anaphylactic shock—Cisplatin—bone cancer	0.000435	0.0107	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000435	0.0107	CcSEcCtD
Methyltestosterone—Paraesthesia—Cisplatin—bone cancer	0.000391	0.00958	CcSEcCtD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000382	0.0223	CbGpPWpGaD
Methyltestosterone—Levonorgestrel—CYP3A4—bone cancer	0.000363	0.0491	CrCbGaD
Methyltestosterone—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000342	0.0199	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Methotrexate—bone cancer	0.000338	0.00828	CcSEcCtD
Methyltestosterone—Haemorrhage—Methotrexate—bone cancer	0.000336	0.00824	CcSEcCtD
Methyltestosterone—Danazol—CYP3A4—bone cancer	0.000331	0.0447	CrCbGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000322	0.0187	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Epirubicin—bone cancer	0.000316	0.00775	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—bone cancer	0.000315	0.00771	CcSEcCtD
Methyltestosterone—Ethinyl Estradiol—CYP3A4—bone cancer	0.000306	0.0414	CrCbGaD
Methyltestosterone—Angiopathy—Methotrexate—bone cancer	0.000305	0.00748	CcSEcCtD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000305	0.0177	CbGpPWpGaD
Methyltestosterone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000303	0.0176	CbGpPWpGaD
Methyltestosterone—Prednisone—CYP3A4—bone cancer	0.000299	0.0404	CrCbGaD
Methyltestosterone—Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.000297	0.0402	CrCbGaD
Methyltestosterone—Alopecia—Methotrexate—bone cancer	0.000297	0.00728	CcSEcCtD
Methyltestosterone—Norethindrone—CYP3A4—bone cancer	0.000294	0.0398	CrCbGaD
Methyltestosterone—Haemoglobin—Doxorubicin—bone cancer	0.000293	0.00717	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—bone cancer	0.000291	0.00714	CcSEcCtD
Methyltestosterone—Angiopathy—Epirubicin—bone cancer	0.000285	0.007	CcSEcCtD
Methyltestosterone—Alopecia—Epirubicin—bone cancer	0.000278	0.00682	CcSEcCtD
Methyltestosterone—Prednisolone—CYP3A4—bone cancer	0.000275	0.0372	CrCbGaD
Methyltestosterone—CYP19A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000273	0.0159	CbGpPWpGaD
Methyltestosterone—Angiopathy—Doxorubicin—bone cancer	0.000264	0.00648	CcSEcCtD
Methyltestosterone—Nausea—Cisplatin—bone cancer	0.000259	0.00634	CcSEcCtD
Methyltestosterone—Alopecia—Doxorubicin—bone cancer	0.000257	0.00631	CcSEcCtD
Methyltestosterone—AR—Generic Transcription Pathway—ZNF77—bone cancer	0.000255	0.0149	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Methotrexate—bone cancer	0.000239	0.00586	CcSEcCtD
Methyltestosterone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000235	0.0137	CbGpPWpGaD
Methyltestosterone—Anxiety—Epirubicin—bone cancer	0.000232	0.0057	CcSEcCtD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—CDK4—bone cancer	0.000226	0.0132	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Epirubicin—bone cancer	0.000224	0.00548	CcSEcCtD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000223	0.013	CbGpPWpGaD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000221	0.0129	CbGpPWpGaD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000218	0.0127	CbGpPWpGaD
Methyltestosterone—Anxiety—Doxorubicin—bone cancer	0.000215	0.00527	CcSEcCtD
Methyltestosterone—Paraesthesia—Methotrexate—bone cancer	0.000214	0.00526	CcSEcCtD
Methyltestosterone—Hydrocortisone—CYP3A4—bone cancer	0.000211	0.0285	CrCbGaD
Methyltestosterone—Anaphylactic shock—Doxorubicin—bone cancer	0.000207	0.00507	CcSEcCtD
Methyltestosterone—Paraesthesia—Epirubicin—bone cancer	0.000201	0.00492	CcSEcCtD
Methyltestosterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000195	0.0114	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Doxorubicin—bone cancer	0.000186	0.00455	CcSEcCtD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000179	0.0104	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000174	0.0101	CbGpPWpGaD
Methyltestosterone—Progesterone—CYP3A4—bone cancer	0.000172	0.0232	CrCbGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—RB1—bone cancer	0.000168	0.0098	CbGpPWpGaD
Methyltestosterone—Testosterone—CYP3A4—bone cancer	0.000162	0.0219	CrCbGaD
Methyltestosterone—Headache—Methotrexate—bone cancer	0.00015	0.00367	CcSEcCtD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000144	0.00839	CbGpPWpGaD
Methyltestosterone—Nausea—Methotrexate—bone cancer	0.000142	0.00348	CcSEcCtD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000142	0.00826	CbGpPWpGaD
Methyltestosterone—Headache—Epirubicin—bone cancer	0.00014	0.00343	CcSEcCtD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00014	0.00815	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000138	0.00806	CbGpPWpGaD
Methyltestosterone—Nausea—Epirubicin—bone cancer	0.000133	0.00325	CcSEcCtD
Methyltestosterone—AR—FOXA1 transcription factor network—JUN—bone cancer	0.000131	0.00765	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—DHFR—bone cancer	0.000131	0.0076	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.00013	0.00759	CbGpPWpGaD
Methyltestosterone—Headache—Doxorubicin—bone cancer	0.00013	0.00318	CcSEcCtD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000126	0.00732	CbGpPWpGaD
Methyltestosterone—CYP19A1—Tryptophan metabolism—MDM2—bone cancer	0.000126	0.00731	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000125	0.00729	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ZNF77—bone cancer	0.000123	0.00716	CbGpPWpGaD
Methyltestosterone—Nausea—Doxorubicin—bone cancer	0.000123	0.00301	CcSEcCtD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000123	0.00714	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000121	0.00705	CbGpPWpGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000115	0.0067	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—SPARC—bone cancer	0.000114	0.00666	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.000113	0.00659	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000112	0.0065	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000109	0.00635	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000108	0.0063	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000105	0.00614	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000105	0.00611	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000104	0.00606	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000103	0.00597	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000102	0.00592	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.000101	0.00588	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.0001	0.00584	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP3A4—bone cancer	9.51e-05	0.00554	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP3A4—bone cancer	9.38e-05	0.00546	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.09e-05	0.00529	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	9.03e-05	0.00526	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	8.82e-05	0.00514	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NR1I2—bone cancer	8.64e-05	0.00503	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—MDM2—bone cancer	8.6e-05	0.00501	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.5e-05	0.00495	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	8.15e-05	0.00474	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—GSTP1—bone cancer	8.13e-05	0.00474	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.07e-05	0.0047	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	8.06e-05	0.0047	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—GSTP1—bone cancer	8.02e-05	0.00467	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	7.92e-05	0.00462	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.84e-05	0.00457	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	7.6e-05	0.00443	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—JUN—bone cancer	7.48e-05	0.00436	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.96e-05	0.00406	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	6.73e-05	0.00392	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	6.61e-05	0.00385	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	6.54e-05	0.00381	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NDUFA12—bone cancer	6.31e-05	0.00367	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.3e-05	0.00367	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP3A4—bone cancer	6.11e-05	0.00356	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	6.02e-05	0.00351	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—FUS—bone cancer	6e-05	0.0035	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—bone cancer	5.88e-05	0.00342	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	5.79e-05	0.00337	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NDUFA12—bone cancer	5.7e-05	0.00332	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	5.69e-05	0.00331	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	5.64e-05	0.00328	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NT5C3A—bone cancer	5.23e-05	0.00304	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—GSTP1—bone cancer	5.22e-05	0.00304	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	5.15e-05	0.003	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	5.07e-05	0.00295	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	4.9e-05	0.00285	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	4.85e-05	0.00282	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—JUN—bone cancer	4.77e-05	0.00278	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NT5C3A—bone cancer	4.72e-05	0.00275	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.67e-05	0.00272	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	4.64e-05	0.0027	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.5e-05	0.00262	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	4.22e-05	0.00246	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	4.21e-05	0.00245	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NR1I2—bone cancer	4.16e-05	0.00242	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.06e-05	0.00236	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.94e-05	0.0023	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	3.89e-05	0.00227	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	3.85e-05	0.00224	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.66e-05	0.00213	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NDUFA12—bone cancer	3.66e-05	0.00213	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.4e-05	0.00198	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	3.31e-05	0.00193	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	3.23e-05	0.00188	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.19e-05	0.00186	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NDUFA12—bone cancer	3.08e-05	0.00179	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—EIF2S1—bone cancer	3.07e-05	0.00179	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NT5C3A—bone cancer	3.03e-05	0.00177	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—bone cancer	2.92e-05	0.0017	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	2.78e-05	0.00162	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.68e-05	0.00156	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—EZH2—bone cancer	2.67e-05	0.00155	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SPARC—bone cancer	2.62e-05	0.00152	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NT5C3A—bone cancer	2.55e-05	0.00149	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—GNA11—bone cancer	2.39e-05	0.00139	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.37e-05	0.00138	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.34e-05	0.00136	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ENO2—bone cancer	2.29e-05	0.00133	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL3—bone cancer	2.17e-05	0.00126	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—DHFR—bone cancer	2.12e-05	0.00124	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ENO2—bone cancer	2.07e-05	0.0012	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GNA11—bone cancer	1.98e-05	0.00116	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—DHFR—bone cancer	1.92e-05	0.00112	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP3A4—bone cancer	1.8e-05	0.00105	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GNA11—bone cancer	1.79e-05	0.00104	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.79e-05	0.00104	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NDUFA12—bone cancer	1.66e-05	0.000969	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000947	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.62e-05	0.000942	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTP1—bone cancer	1.54e-05	0.000896	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PLAU—bone cancer	1.42e-05	0.000828	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTP1—bone cancer	1.39e-05	0.00081	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NT5C3A—bone cancer	1.38e-05	0.000803	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ENO2—bone cancer	1.33e-05	0.000774	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—DHFR—bone cancer	1.23e-05	0.000718	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GNA11—bone cancer	1.15e-05	0.000671	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ENO2—bone cancer	1.12e-05	0.000651	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP3A4—bone cancer	1.04e-05	0.000608	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—DHFR—bone cancer	1.04e-05	0.000604	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GNA11—bone cancer	9.7e-06	0.000565	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTP1—bone cancer	8.93e-06	0.00052	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP3A4—bone cancer	8.79e-06	0.000512	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.75e-06	0.000509	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—bone cancer	7.97e-06	0.000464	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTP1—bone cancer	7.52e-06	0.000438	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—bone cancer	7.21e-06	0.00042	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ENO2—bone cancer	6.04e-06	0.000352	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—bone cancer	5.72e-06	0.000333	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—DHFR—bone cancer	5.6e-06	0.000326	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GNA11—bone cancer	5.23e-06	0.000305	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—bone cancer	4.63e-06	0.00027	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTP1—bone cancer	4.06e-06	0.000236	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—bone cancer	3.9e-06	0.000227	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—bone cancer	2.1e-06	0.000122	CbGpPWpGaD
